-
The recent AI-driven “scare trade” (investors selling risk assets over fears about AI disrupting businesses) appears to be cooling, however the yesterday US session was very weak.with DJIA dropping mor than 1,65% and Nasdaq 100 tanking 1,2%
-
Yesterday, US software stocks bleeded again with IBM shares down 11% after publishing a new Anthropic Claude functions.
-
Asian stocks moved higher even as US markets had just slipped, with US equity-index futures up about 0.2%, while European stocks were also set for a firmer open.
-
Traders rotated into chipmakers as the “picks and shovels” of the AI supply chain; SK Hynix, Samsung, and TSMC hit new highs.
-
The Asian strength follows Monday’s US decline, led by drops in tech, delivery, and payment names after Citrini Research flagged potential AI risks across industries.
-
The selloff was made worse by lingering uncertainty around Trump-related tariff risks.
-
Regional performance highlights: South Korea +2%, Taiwan +2.7%, and China rose after reopening from Lunar New Year. However, the precious metals are down amid Shanghain exchange reopen.
-
Gold and silver fell after a four-day gains, and Treasuries gave back some gains as haven demand eased.
-
Overall, the MSCI Asia Pacific Index recovered earlier losses and was up about 0.2%.
-
Bitcoin is down 2% and is fluctuating around $63,000 level after the sell-off.
-
Trump Admin believes China's DeepSeek used Nvidia's most advanced AI chip to train its latest model.
(summary in progress)
BREAKING: NFP payrolls skyrocket 🚀 EURUSD back in red 📉
EURUSD catches breath before NFP 📈
Economic Calendar: NFP Data Overshadowed by the Holiday Break
Economic calendar: Smaller US labour market reports set to fight for attention amid geopolitics (02.04.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
